You're contacting media contact of this press release

Title: CoreAge Rx Debuts GLP-1 Support Probiotic and Prebiotic Supplement to Ease Digestive Discomfort

Wichita Falls, TX, United States, 30th Jul 2026 - Digital health provider CoreAge Rx today announced the official release of GLP-1 Support, a specialized daily supplement engineered to mitigate gastrointestinal side effects commonly experienced by individuals on GLP-1 receptor agonist medications, such as semaglutide and tirzepatide. Developed as a gentle, non-stimulant regimen, the new oral supplement promotes gut microbiome balance, reduces bloating, and aids natural bowel regularity without causing severe cramping or urgency.GLP-1 medications typically delay gastric emptying, which can disrupt normal digestive rhythm and lead to occasional constipation and GI distress. To address these underlying physiological changes, CoreAge Rx created a physician-backed blend combining targeted probiotic strains with fermentable prebiotic fibers:Akkermansia muciniphila: Supports intestinal lining integrity and gut barrier health.Bifidobacterium infantis: Promotes overall abdominal comfort and smooth digestion.Clostridium butyricum: Encourages butyrate production, an essential short-chain fatty acid that fuels gut cells.Prebiotic Fiber Blend: Includes 211 mg of Chicory Root Inulin and 100 mg of Potato Resistant Starch to nourish beneficial bacteria and foster microbial diversity.To ensure maximum viability, the ingredients are encased in a vegetarian, delayed-release capsule engineered to bypass harsh stomach acid and deliver live cultures directly to the intestinal tract.The recommended administration is one capsule daily with 8 ounces of water, taken with or without food. CoreAge Rx advises storing the bottle in the refrigerator after opening to preserve strain potency. Formulated by medical professionals and manufactured in a US-based cGMP-certified facility, GLP-1 Support is av...

This press release is issued by King Newswire